Hearing:
“Unsustainable Drug Prices: Testimony from the CEOs (Part I and Part II)”
Committee on Oversight and Reform
Wednesday, September 30, 2020 (10:00 AM)
2154 RHOB
Washington, D.C.
This is a two part hearing on Sept. 30th and Oct. 1st, both starting at 10am.
This is a hybrid in person/remote hearing.
Witnesses
Mr. Mark Alles
Former Chairman of the Board and Chief Executive Officer, Celgene Corporation
Added
09/28/2020 at 01:44 PM
- Witness Statement
[PDF]
Added
09/30/2020 at 03:12 PM
Dr. Giovanni Caforio
Chairman of the Board and Chief Executive Officer, Bristol Myers Squibb Company
Added
09/28/2020 at 01:44 PM
- Witness Statement
[PDF]
Added
09/30/2020 at 03:12 PM
Mr. Kare Schultz
President and Chief Executive Officer, Teva Pharmaceutical Industries Ltd.
Added
09/28/2020 at 01:44 PM
- Witness Statement
[PDF]
Added
09/30/2020 at 03:12 PM
Support Documents
- Notice
[PDF]
Added
09/22/2020 at 09:29 AM
- Memo
[PDF]
Added
09/25/2020 at 03:58 PM
Hearing Record
- Attendance
[PDF]
Added
09/30/2020 at 02:21 PM
- QFR's from Chairwoman Maloney and Rep Porter to Caforio
[PDF]
Added
11/17/2020 at 02:27 PM
- Hearing Transcript
[PDF]
Added
12/18/2020 at 10:39 AM
First Published:
September 22, 2020 at 09:28 AM
Last Updated:
December 18, 2020 at 10:39 AM